Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified May 2014 by Seoul National University Hospital
Sponsor:
Collaborator:
Soonchunhyang University Hospital
Information provided by (Responsible Party):
YOUNG HO KIM, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01663467
First received: August 8, 2012
Last updated: May 13, 2014
Last verified: May 2014

August 8, 2012
May 13, 2014
September 2014
September 2014   (final data collection date for primary outcome measure)
Tinnitus Handicap Inventory (THI) [ Time Frame: 6 months ] [ Designated as safety issue: No ]
THI will be evaluated 6 months after TRT using smatrphone and web
Same as current
Complete list of historical versions of study NCT01663467 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
Efficacy of Internet and Smartphone Application-delivered TRT

The purpose of this study is to prove the efficacy of the internet and smartphone application-delivered tinnitus retraining therapy (TRT).

to investigate the effect of TRT with minimized counseling

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Tinnitus
  • Drug: Ginkgo biloba
    Other Name: Ginexin-F
  • Behavioral: modified tinnitus retraining therapy (TRT)
  • Active Comparator: Ginkgo biloba only
    control group Ginexin-F 80mg tablet will be given twice a day for 6 months.
    Intervention: Drug: Ginkgo biloba
  • Experimental: Ginkgo biloba + modified TRT

    experimental group modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba.

    Ginexin-F 80mg tablet will be given twice a day for 6 months.

    Interventions:
    • Drug: Ginkgo biloba
    • Behavioral: modified tinnitus retraining therapy (TRT)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
48
December 2014
September 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • chronic subjective tinnitus

Exclusion Criteria:

  • THI < 18
Both
20 Years to 65 Years
No
Contact: YOUNG HO KIM, MD., PhD 82-10-3325-1018 yhkiment@gmail.com
Contact: MOO KYUN PARK, MD., PhD 82-10-5145-3946 aseptic@schmc.ac.kr
Korea, Republic of
 
NCT01663467
SNUH_YHK_TRT
No
YOUNG HO KIM, Seoul National University Hospital
Seoul National University Hospital
Soonchunhyang University Hospital
Study Chair: YOUNG HO KIM, MD., PhD Seoul National University Hospital
Seoul National University Hospital
May 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP